EAM

Exome Asset Management Portfolio holdings

AUM $151M
1-Year Est. Return 46.2%
This Quarter Est. Return
1 Year Est. Return
+46.2%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$112M
AUM Growth
-$21.3M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
78
New
Increased
Reduced
Closed

Top Buys

1
+$4.73M
2
+$3.72M
3
+$2.93M
4
RGNX icon
Regenxbio
RGNX
+$2.9M
5
DYN icon
Dyne Therapeutics
DYN
+$2.7M

Top Sells

1
+$4.58M
2
+$4.46M
3
+$3.81M
4
BMY icon
Bristol-Myers Squibb
BMY
+$3.69M
5
BSX icon
Boston Scientific
BSX
+$3.62M

Sector Composition

1 Healthcare 98.64%
2 Financials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
26
$2.05M 1.82%
+25,400
27
$1.98M 1.76%
689,137
+405,538
28
$1.78M 1.58%
102,944
-49,021
29
$1.78M 1.58%
+263,841
30
$1.77M 1.57%
6,500
-3,500
31
$1.72M 1.53%
+51,295
32
$1.57M 1.4%
71,438
-10,035
33
$1.55M 1.38%
117,500
34
$1.54M 1.37%
+289,690
35
$1.52M 1.35%
148,830
+107,618
36
$1.37M 1.22%
195,295
-23,405
37
$1.21M 1.07%
1,097,999
38
$1.03M 0.92%
+163,738
39
$982K 0.87%
+133,113
40
$959K 0.85%
39,900
+11,741
41
$871K 0.77%
90,100
42
$731K 0.65%
462,801
+109,367
43
$535K 0.48%
13,100
44
$455K 0.4%
+60,600
45
$387K 0.34%
114,145
-142,228
46
$363K 0.32%
189,087
-16,869
47
$170K 0.15%
+96,311
48
$59.1K 0.05%
28,972
-98,988
49
– –
-1,083,487
50
– –
0
1
2
3 4